Identification | Back Directory | [Name]
Sb-742457 | [CAS]
607742-69-8 | [Synonyms]
CS-579 RVT-101 CS-2723 Sb 742457 Sb-742457 Gsk 742457 SB-742457(RVT-101) Sb-742457 USP/EP/BP RVT101. intepirdine. SB742457:Intepirdine SB 742457/GSK 742457 Intepirdine(SB742457) Intepirdine (SB-742457, RVT-101) SB 742457;RVT 101;SB742457;RVT101 3-Phenylsulfonyl-8-(piperazin-1-yl)quinoline 3-(BENZENESULFONYL)-8-(PIPERAZIN-1-YL)QUINOLINE Quinoline, 3-(phenylsulfonyl)-8-(1-piperazinyl)- SB742457; SB 742457; SB-742457; RVT-101; RVT 101; RVT101. INTEPIRDINE. | [Molecular Formula]
C19H19N3O2S | [MDL Number]
MFCD12828872 | [MOL File]
607742-69-8.mol | [Molecular Weight]
353.44 |
Chemical Properties | Back Directory | [Boiling point ]
608.3±45.0 °C(Predicted) | [density ]
1.292 | [storage temp. ]
Store at -20°C | [solubility ]
insoluble in H2O; ≥17.65 mg/mL in DMSO; ≥2.13 mg/mL in EtOH with gentle warming and ultrasonic | [form ]
solid | [pka]
8?+-.0.10(Predicted) | [color ]
Light yellow to yellow | [InChI]
InChI=1S/C19H19N3O2S/c23-25(24,16-6-2-1-3-7-16)17-13-15-5-4-8-18(19(15)21-14-17)22-11-9-20-10-12-22/h1-8,13-14,20H,9-12H2 | [InChIKey]
JJZFWROHYSMCMU-UHFFFAOYSA-N | [SMILES]
N1C2C(=CC=CC=2N2CCNCC2)C=C(S(C2=CC=CC=C2)(=O)=O)C=1 |
Hazard Information | Back Directory | [Description]
SB-742457 is an orally bioavailable antagonist of the serotonin (5-HT) receptor subtype 5-HT6 (Ki = 1.4 nM).1,2 SB-742457 (1 μM) also binds to 5-HT1B, 5-HT2A, 5-HT2B, and 5-HT2C receptors with high affinity.3 SB-742457 reduces 5-HT6 activation of Gs-mediated cAMP production in a concentration-dependent manner with an EC50 value of 21 nM in NG108-15 neuroblastoma cells.2 In vivo, SB-742457 (1.5 mg/kg, p.o.) reverses deficits in novel object recognition induced by scopolamine (Item No. 14108) in rats.1 It also reverses age-induced impairments in spatial memory acquisition and retention in rats in the Morris water maze. SB-742457 (3.0 mg/kg, i.p.) reduces the number of licking bouts by 24% compared with control in rats trained to lick a glucose solution, indicating a role in satiety and obesity management.4 | [Uses]
SB 742457 is a selective 5-HT6 receptor antagonist which is known to be involved in improving cognitive function. | [Synthesis]
To a 100 mL three-neck flask was added Pd2(dba)3 (174 mg, 0.19 mmol, 0.03 equiv), 8-iodo-3-benzenesulfonylquinoline (2.5 g, 6.33 mmol), 1,1'-bis(diphenylphosphino)ferrocene (316 mg, 0.57 mmol), sodium tert-butoxide (851 mg, 8.86 mmol, 1.4 equivalents) and piperazine (2.72 g, 31.6 mmol, 5 equivalents). The flask was evacuated and displaced 4 times with nitrogen, then anhydrous 1,4-dioxane (17.5 mL, 7 vol) was added. The mixture was stirred and heated to 40 °C for 16 hours of reaction. After completion of the reaction, the dark solution was cooled to room temperature, dichloromethane (12.5 mL) was added and washed with deionized water (12.5 mL). The aqueous phase was extracted with dichloromethane and the combined organic phases were extracted with 5 M HCl (2 x 12.5 mL). The combined aqueous phases were washed with dichloromethane (2.5 mL) and transferred to a conical flask, dichloromethane (12.5 mL) was added and the flask was cooled in an ice water bath. An aqueous 1 M sodium hydroxide solution (13 mL) was added with stirring and the mixture was then stirred at room temperature until all solids were dissolved. The lower organic phase was separated, the aqueous phase was extracted with dichloromethane (7.5 mL), and the combined organic phases were concentrated under reduced pressure to about 5 mL. Crystallization was induced by the addition of iso-octane (2.5 mL) to the dark brown solution, and the mixture was stirred at room temperature for 5 minutes, followed by the slow addition of iso-octane (22.5 mL) over a 5 minute period. The mixture was aged at room temperature for 1.5 hours, then cooled in an ice water bath for 30 minutes, filtered and the filter cake was washed with isooctane (5 mL). The filter cake was dried under reduced pressure to afford the target product 3-(phenylsulfonyl)-8-(piperazin-1-yl)quinoline (1.67 g, 75% yield).1H NMR (CDCl3) δ: 1.6 (1H, bs), 3.18 (4H, m), 3.34 (4H, m), 7.27 (1H, m), 7.49-7.60 (5H, m), 8.01 (2H, dd), 8.75 (1H, d), 9.21 (1H, d). | [target]
5-HT6 | [IC 50]
5-HT6 Receptor: 9.63 (pKi) | [References]
[1] aaron t. t. chuang, andrew foley, perdita l. pugh, david sunter, xin tong, ciaran regan, lee a. dawson, andrew d. medhurst, neil upton.5-ht6 receptor antagonist sb-742457 as a novel cognitive enhancing agent for alzheimer’s disease. alzheimer's & dementia: the journal of the alzheimer's association volume 2, issue 3, supplement, pages s631–s632, july 2006 |
|
|